Liquid metronidazole for children with bacterial infections
Part of Infections clinical trials.
This study tests a liquid form of the antibiotic metronidazole (called Likmez) in young children with certain bacterial infections. The goal is to see how the medicine is processed in the body and to check its safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 12 months and just under 4 years old at the time of dosing.
- Your child must be able to swallow oral liquids.
- Your child has a confirmed or suspected bacterial infection that needs treatment, such as a blood infection, an infection in the belly, a bone or joint infection, or a lung infection like pneumonia.
- Your child has not had a severe allergic reaction to metronidazole (or similar drugs) in the past.
- Your child does not have a history of seizures or certain blood, liver, or kidney problems that could make the study risky.
- A parent or legal guardian must give written permission for the child to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body processes oral antibiotics in young babies. It aims to help doctors choose the right doses by studying how these medicines move through the body.
This trial tests whether a postbiotic (a product made from beneficial bacteria) called Lactéol® is safe for children with diarrhea who have weakened immune systems. It aims to help manage diarrhea and improve recovery.
This trial compares two antibiotic treatments for liver abscess: one given through an IV (into a vein) and one taken as pills by mouth. The goal is to see if the oral treatment works just as well, which could make treatment easier and more convenient for patients.
This study tests if an injection of the antibiotic metronidazole directly into skin sores can help heal leishmaniasis, a parasite infection from sandfly bites. It's for people with fewer than seven sores.
This study tests two new investigational drugs to treat bacterial vaginosis. It aims to see if these drugs are safe and work well. If you have BV, this trial could give you access to a new treatment option.
This study tests whether a medicine called rifaximin, taken along with oral rehydration solution, helps children aged 6 to 11 recover faster from acute (short-lasting) diarrhea that is likely caused by a bacterial infection. The study compares rifaximin plus oral rehydration versus oral rehydration alone.
Hear when a new Bacterial Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.